TXG logo

10x Genomics, Inc. (TXG) Cash From Financing

Annual CFF:

$10.91M-$2.75M(-20.16%)
December 31, 2024

Summary

  • As of today, TXG annual cash from financing is $10.91 million, with the most recent change of -$2.75 million (-20.16%) on December 31, 2024.
  • During the last 3 years, TXG annual cash from financing has fallen by -$24.38 million (-69.08%).
  • TXG annual cash from financing is now -97.67% below its all-time high of $468.91 million, reached on December 31, 2020.

Performance

TXG Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTXGcash flow metrics

Quarterly CFF:

$617.00K-$2.90M(-82.48%)
September 30, 2025

Summary

  • As of today, TXG quarterly cash from financing is $617.00 thousand, with the most recent change of -$2.90 million (-82.48%) on September 30, 2025.
  • Over the past year, TXG quarterly cash from financing has increased by +$461.00 thousand (+295.51%).
  • TXG quarterly cash from financing is now -99.87% below its all-time high of $486.97 million, reached on September 30, 2020.

Performance

TXG Quarterly Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTXGcash flow metrics

TTM CFF:

$9.08M+$461.00K(+5.35%)
September 30, 2025

Summary

  • As of today, TXG TTM cash from financing is $9.08 million, with the most recent change of +$461.00 thousand (+5.35%) on September 30, 2025.
  • Over the past year, TXG TTM cash from financing has dropped by -$2.93 million (-24.41%).
  • TXG TTM cash from financing is now -98.24% below its all-time high of $514.38 million, reached on June 30, 2021.

Performance

TXG TTM Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTXGcash flow metrics

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

TXG Cash From Financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-20.2%+295.5%-24.4%
3Y3 Years-69.1%-69.7%-54.0%
5Y5 Years-97.4%-99.9%-98.0%

TXG Cash From Financing Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-69.1%at low-91.3%+118.1%-54.0%+5.3%
5Y5-Year-97.7%at low-99.9%+118.1%-98.2%+5.3%
All-TimeAll-Time-97.7%at low-99.9%+101.8%-98.2%>+9999.0%

TXG Cash From Financing History

DateAnnualQuarterlyTTM
Sep 2025
-
$617.00K(-82.5%)
$9.08M(+5.3%)
Jun 2025
-
$3.52M(+734.6%)
$8.62M(-11.1%)
Mar 2025
-
$422.00K(-90.7%)
$9.70M(-11.1%)
Dec 2024
$10.91M(-20.2%)
$4.52M(+2795.5%)
$10.91M(-9.1%)
Sep 2024
-
$156.00K(-96.6%)
$12.01M(-26.0%)
Jun 2024
-
$4.60M(+181.0%)
$16.23M(-13.3%)
Mar 2024
-
$1.64M(-70.8%)
$18.72M(+37.0%)
Dec 2023
$13.67M(-13.6%)
$5.61M(+28.3%)
$13.67M(+4.7%)
Sep 2023
-
$4.37M(-38.4%)
$13.06M(+21.8%)
Jun 2023
-
$7.10M(+307.9%)
$10.72M(+7.4%)
Mar 2023
-
-$3.41M(-168.3%)
$9.99M(-36.9%)
Dec 2022
$15.82M
$5.00M(+145.3%)
$15.82M(-19.8%)
Sep 2022
-
$2.04M(-67.9%)
$19.72M(-19.1%)
Jun 2022
-
$6.36M(+163.1%)
$24.36M(-28.8%)
DateAnnualQuarterlyTTM
Mar 2022
-
$2.42M(-72.9%)
$34.20M(-3.1%)
Dec 2021
$35.30M(-92.5%)
$8.90M(+33.2%)
$35.30M(+3.5%)
Sep 2021
-
$6.68M(-58.7%)
$34.10M(-93.4%)
Jun 2021
-
$16.19M(+360.3%)
$514.38M(+1.6%)
Mar 2021
-
$3.52M(-54.3%)
$506.24M(+8.0%)
Dec 2020
$468.91M(+13.1%)
$7.71M(-98.4%)
$468.91M(+1.9%)
Sep 2020
-
$486.97M(+5948.5%)
$460.09M(+18.3%)
Jun 2020
-
$8.05M(+123.8%)
$388.76M(+2.3%)
Mar 2020
-
-$33.82M(-2955.0%)
$379.85M(-8.4%)
Dec 2019
$414.59M(+293.5%)
-$1.11M(-100.3%)
$414.59M(-0.3%)
Sep 2019
-
$415.64M(>+9900.0%)
$415.70M(>+9900.0%)
Jun 2019
-
-$864.00K(-193.6%)
$59.00K(-93.6%)
Mar 2019
-
$923.00K
$923.00K
Dec 2018
$105.37M(+411.9%)
-
-
Dec 2017
$20.58M
-
-

FAQ

  • What is 10x Genomics, Inc. annual cash from financing?
  • What is the all-time high annual cash from financing for 10x Genomics, Inc.?
  • What is 10x Genomics, Inc. annual cash from financing year-on-year change?
  • What is 10x Genomics, Inc. quarterly cash from financing?
  • What is the all-time high quarterly cash from financing for 10x Genomics, Inc.?
  • What is 10x Genomics, Inc. quarterly cash from financing year-on-year change?
  • What is 10x Genomics, Inc. TTM cash from financing?
  • What is the all-time high TTM cash from financing for 10x Genomics, Inc.?
  • What is 10x Genomics, Inc. TTM cash from financing year-on-year change?

What is 10x Genomics, Inc. annual cash from financing?

The current annual cash from financing of TXG is $10.91M

What is the all-time high annual cash from financing for 10x Genomics, Inc.?

10x Genomics, Inc. all-time high annual cash from financing is $468.91M

What is 10x Genomics, Inc. annual cash from financing year-on-year change?

Over the past year, TXG annual cash from financing has changed by -$2.75M (-20.16%)

What is 10x Genomics, Inc. quarterly cash from financing?

The current quarterly cash from financing of TXG is $617.00K

What is the all-time high quarterly cash from financing for 10x Genomics, Inc.?

10x Genomics, Inc. all-time high quarterly cash from financing is $486.97M

What is 10x Genomics, Inc. quarterly cash from financing year-on-year change?

Over the past year, TXG quarterly cash from financing has changed by +$461.00K (+295.51%)

What is 10x Genomics, Inc. TTM cash from financing?

The current TTM cash from financing of TXG is $9.08M

What is the all-time high TTM cash from financing for 10x Genomics, Inc.?

10x Genomics, Inc. all-time high TTM cash from financing is $514.38M

What is 10x Genomics, Inc. TTM cash from financing year-on-year change?

Over the past year, TXG TTM cash from financing has changed by -$2.93M (-24.41%)
On this page